Meeting
2018 ASCO Annual Meeting
Human leukocyte antigen (HLA) B44 supertype and immunotherapy outcomes in non-small cell lung cancer (NSCLC).
Authors
Henry Lu
University of Virginia School of Medicine, Charlottesville, VA
Henry Lu , Amy Lauren Cummings , Jonathan Wade Goldman , Aaron Elliott Lisberg , Siwen Hu-Lieskovan , Tristan Grogan , Jaklin Gukasyan , John Madrigal , James M. Carroll , Krikor Bornazyan , Benjamin Jones , Zorawar Singh Noor , Jesse Meir Zaretsky , David Elashoff , Dennis J. Slamon , Steven M. Dubinett , Edward B. Garon
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Immunotherapy
Track
Developmental Therapeutics and Translational Research
Sub Track
Biomarkers and Correlative Studies from Immunotherapy Trials
Citation
J Clin Oncol 36, 2018 (suppl; abstr 3026)
DOI
10.1200/JCO.2018.36.15_suppl.3026
Abstract #
3026
Poster Bd #
240
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Impact of smoking status (SS) on the clinical outcomes of patients with metastatic renal cell carcinoma (mRCC) treated with first line (1L) immuno-oncology (IO)-combination regimens: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
First Author: Georges Gebrael
Poster
2022 ASCO Annual Meeting
Comprehensive genomic and immune profiling defines immunotherapy treatment in patients with NSCLC with low PD-L1 IHC.
First Author: Sarabjot Pabla
Poster
2019 ASCO Annual Meeting
Intra and perinodular CT delta radiomic features associated with early response to predict overall survival (OS) in immunotherapy-treated non-small cell lung cancer (NSCLC): A multi-site multi-agent study.
First Author: Prateek Prasanna
Poster
2019 ASCO Annual Meeting
Electrostatic human leukocyte antigen-neoantigen interactions and durable benefit in non-small cell lung cancer patients treated with immunotherapy.
First Author: Amy Lauren Cummings